A federal appellate court in Washington, D.C. is fast-tracking Novartis and Bristol Myers Squibb’s (BMS) appeal of a lower court [...] …
Blog Posts
SPONSORED CONTENT
AI is everywhere—chatbots, smart assistants, predictive tools. But in 340B? The line between what’s useful and what’s just marketing is getting
…
The Centers for Medicare and Medicaid Services (CMS) released new details this week to help stakeholders navigate the Inflation Reduction [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Maxor, a leading integrated pharmacy services and 340B solutions provider first established nearly 100 years ago in a small Texas [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Three major drugmakers recently announced refunds for 340B covered entities that purchased certain drugs in 2022 and 2023 following recalculations [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
SPONSORED CONTENT
TIP: Align charge capture and 340B strategy to unlock long-term sustainability.
In today’s margin-pressured environment, 340B savings
In the final hour of Oklahoma’s 2025 legislative session, as the clock neared 11 p.m. on May 29, state legislators [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A key health policy staffer for U.S. Senate Health, Education, Labor and Pensions (HELP) Committee Chairman Bill Cassidy (R-La.) recently [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
For the third straight time in 2025, a federal audit has found a drug manufacturer overcharged covered entities for 340B [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Two drugmakers recently added new medications to the list of drugs subject to their respective 340B contract pharmacy restrictions—one of [...] …